Navigation Links
Hope for Marburg treatment: vaccine successful in primates

The deadly Marburg virus that had affected a total of 423 cases in Angola,// which had left 357 dead, may finally have a treatment in the form of a vaccine.

A virus causes Marburg hemorrhagic fever from the same family of virus that cause Ebola hemorrhagic fever. The disease is a rare condition but have the potential of causing an outbreak very fast. The symptoms begin with severe headaches and feeling of severe unwell. Patients develop severe hemorrhagic manifestations and often turn fatal with bleedings from various locations. There is no specific treatment currently available.

In another trial a few years ago, researchers from National Institutes of Health, US, had developed a vaccine from dead virus called adenovirus. This vaccine had protected macaques from the Ebola virus.

In a new research, scientists from Public Health Agency of Canada have developed the vaccine from live deactivated virus that is said to be more effective as it is required in small doses and is easier to produce. The vaccine is med from the virus that causes the disease vesicular stomatitis in the farm animals. After genetically modifying the virus to make it harmless, inoculations of the live virus makes the human bodies to identify the protein coverings of the virus and makes them fight the virus of Ebola and Marburg. The scientists had been able to successfully test the vaccine in macaques
'"/>




Page: 1

Related medicine news :

1. New Vaccine To Combat The Deadly Marburg Virus
2. Mainstream medicine collides with alternate treatment: increasing health risks
3. New hope for cancer victims – will vaccine cure the deadly bug
4. New vaccine helps allergy and asthma patients
5. Man against HIV – new vaccine ready for human trials
6. New vaccine helps allergy and asthma patients
7. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
8. HIV did not arise from polio vaccine
9. Double impact vaccine
10. High Demand for a child vaccine
11. A new vaccine for leukemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... ... America Walks , a national advocacy organization that promotes walking and ... Pittsburgh Graduate School of Public Health , has been awarded a Walking College ... around the country to participate in a four-month training program designed to strengthen local ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows ... your footage," said Christina Austin - CEO of Pixel Film Studios. , With ... and easily add stylish color grades to their footage. A LUT is a Lookup ...
(Date:5/25/2016)... ... May 25, 2016 , ... Consumer access to organic foods and grower access ... maker of whole grain cereals and other plant-based foods, will introduce the first consumer ... winter wheat processed by Hesco/Dakota Organic Products. , The transitional designation means the cereal ...
(Date:5/25/2016)... ... 25, 2016 , ... Stern Environmental Group , of Secaucus, New Jersey, ... as Stern’s Real Time Monitoring (RTM) Device. Stern Environmental Group will sell ... industry, colleges for use in dormitories, shelters, and nursing homes for real time bedbug ...
(Date:5/24/2016)... ... 2016 , ... Sterling Global Products is launching a Kickstarter campaign focused on ... dispenser. The campaign kick-off video is located via this link https://youtu.be/WsO4qz2odco . The ... is to raise $1,000 per day for a total of $25,000. The funds will ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 The World Health Organization ... device to include adolescents aged 13 years, and above. ... be offered for adult and adolescent males in the 14 ... . PrePex was the first male circumcision device to receive ... CEO, Eddy Horowitz said: " The expanded ...
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
Breaking Medicine Technology: